Impact of Levofloxacin on Clinical Outcomes π§πΌπ
Impact of Levofloxacin on Clinical Outcomes π§πΌπ
Created using ChatSlide
This presentation explores the impact of Levofloxacin on clinical outcomes in children, particularly within the context of MDR-TB prevention. Conducted through the TB-CHAMP trial, the study assesses the antibiotic's safety, growth effects, and infection rates over a 24-week period among South African children under five. Findings indicate improved haemoglobin levels, reduced infections, and no adverse growth effects, suggesting potential ancillary benefits beyond tuberculosis control. This...